Clinical outcome and prognostic factors of patients with early-stage epithelial ovarian cancer
Wei Wei(Zhujiang Hospital), Lingying Wu(Chang Gung University), Bin Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Ning Li(Shenyang Pharmaceutical University), Yangchun Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Lily Xu(Wellesley College)
Cited by 61
Related Papers
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
|Journal of Clinical Oncology|2020|217
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma
|Therapeutic Advances in Medical Oncology|2021|216